Identification | Back Directory | [Name]
Vonlerolizumab | [CAS]
1638935-72-4 | [Synonyms]
MOXR0916 MOXR 0916 Vonlerolizumab Research Grade Pogalizumab (DHE43202) |
Hazard Information | Back Directory | [Uses]
Vonlerolizumab (MOXR 0916) is a humanized IgG agonistic monoclonal OX40-specific antibody. Vonlerolizumab can be used for the research of cancer[1]. | [References]
[1] Marin-Acevedo JA, et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 15;11(1):39. DOI:10.1186/s13045-018-0582-8 |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 18108604356 |
Website: |
www.biolabreagent.com/ |
|